Li et al. found that luteolin suppressed activation of hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways 24. This evidence concerns the gene RPS6KB1 and Hepatic fibrosis.